| 标题 |
Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy |
| 网址 | |
| DOI |
10.1182/blood.2024024776
doi
|
| 其它 |
期刊:Blood 作者:Laura N Eadie; Elias Lagonik; Elyse C Page; Caitlin E Schutz; Susan L. Heatley; et al 出版日期:2024-06-07 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)